-
Illustrating the Unconventional: PROTAC™ Technology for Disease Therapy
By
Michael Astrachan
XVIVO, in collaboration with Wyant Simboli and their client, Arvinas Inc., helped communicate the unconventional …
-
By
Michael Astrachan
To kick-off the New Year, we’re launching a fresh new showreel for XVIVO. 2018 was …
-
Snip, Snip: New Genome Editing Tools in Development
By
Michael Astrachan
The NIH Somatic Cell Genome Editing program is supporting development of new tools and tests …
-
XVIVO and PBS Present: My Love Affair with the Brain
By
Michael Astrachan
On March 9th, your knowledge of the human brain will be challenged and revitalized through …
-
Rare Diseases Deserves a Voice
By
Michael Astrachan
Heart disease affects 1 out of every 4 people in the United States.Breast cancer affects 1 out of …
-
By
Michael Astrachan
XVIVO created an animation that provides a 30,000-foot overview of neurophysiological signaling in the human …
-
Listerine Dental Biofilm, Dysbiosis & Disease – A VR Experience
By
Michael Astrachan
It’s all about the biofilm. Over 700 different species are found in the human oral …
-
By
Michael Astrachan
XVIVO partnered with Lexicon Pharmaceuticals to create a series of high end medical animations that …
-
A FOCUS ON ALK-POSITIVE NON-SMALL CELL LUNG CANCER
By
Michael Astrachan
In partnership with Wedgewood Communications, XVIVO developed two videos for Takeda Oncology to discuss lung …
-
Biostage Cellframe Technology
By
Michael Astrachan
Esophageal cancer affects over 450,000 people worldwide. In the United States, approximately 17,000 people are …